Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.

Authors

null

Albert Abad

Hosp Univ Germans Trias I Pujol, Barcelona, Spain

Albert Abad , Jose M Vieitez , Vicente Alonso , Pilar Garcia Alfonso , Jose Luis Manzano , Bartomeu Massuti , Manuel Benavides , Alfredo Carrato , Jordi Remon , Javier Gallego Plazas , Veronica Conde , Cristina Gravalos Castro , Manuel Valladares , Mariano Provencio , Ramon Salazar , Manuel Gallen , Fernando Rivera , Javier Sastre , Enrique Aranda , Eva Martinez-Balibrea

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT01071655

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3530)

DOI

10.1200/JCO.2016.34.15_suppl.3530

Abstract #

3530

Poster Bd #

227

Abstract Disclosures